Comprehensive Analysis of the Global Clinical Trials IndustryThe global clinical trials sector is experiencing a significant ...

Now coming from a background in biochemistry and molecular biology, I found that a big part of drug development ... First, though, there are decentralized clinical trials that bring new data ...

Clinical trials are often conducted at a limited number of hospitals, forcing remote patients to bear high travel burdens and frequently withdraw from trials. Additionally, decentralized trial ...

Decentralised clinical trials (DCTs) have become a major talking point due to their ability to ensure that drug development ... “Prior to the pandemic, decentralized trials were gaining industry ...

She does agree that moving to a decentralized manufacturing model ... about the potential for real-time data analysis in clinical trials, which she believes will “completely change the dynamics of ...

on the importance of integrating patient voices into clinical trial design while addressing participation burdens and ensuring post-trial drug access. Another keynote panel with industry leaders from ...

FDA Commissioner Marty Makary’s proposal to roll out a new drug approval pathway is heightening hope for the rare disease ...

Explore the evolving landscape of clinical trials in drug discovery and learn about recent breakthroughs transforming the ...

By embracing a mix of co-innovation and best practices, stakeholders can boost productivity, streamline clinical trials, and ...